---
title: "TELA.US (TELA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TELA.US/news.md"
symbol: "TELA.US"
name: "TELA.US"
parent: "https://longbridge.com/en/quote/TELA.US.md"
datetime: "2026-05-20T13:53:11.051Z"
locales:
  - [en](https://longbridge.com/en/quote/TELA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TELA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TELA.US/news.md)
---

# TELA.US (TELA.US) — Related News

### [Tela Bio | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 19.06 M](https://longbridge.com/en/news/286151752.md)
*2026-05-12T20:21:20.000Z*
### [TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://longbridge.com/en/news/285995355.md)
*2026-05-11T20:31:16.000Z*
> TELA Bio, Inc. (NASDAQ: TELA) announced on May 7, 2026, that its Board of Directors authorized inducement grants of 89,2

### [TELA Bio (TELA) Projected to Post Earnings on Tuesday](https://longbridge.com/en/news/285248776.md)
*2026-05-05T18:23:14.000Z*
> TELA Bio (NASDAQ: TELA) is set to release its Q1 2026 earnings on May 12, with analysts predicting a loss of $0.14 per s

### [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://longbridge.com/en/news/284897248.md)
*2026-05-01T12:05:59.000Z*
> In Friday's pre-market session, Cue Biopharma saw a significant gain of 90.1%, reaching $28.02, while Esperion Therapeut

### [](https://longbridge.com/en/news/284928659.md)
*2026-05-01T17:59:48.000Z*
> TELA Bio shares are trading higher after the company reported preliminary Q1 sales results above prior guidance. Also, t

### [TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues | TELA Stock News](https://longbridge.com/en/news/284833405.md)
*2026-04-30T12:45:36.000Z*
> TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and